IMU Biosciences

📍 London, United Kingdom🗓 Founded 2019👥 44 employees💰 Last funded Oct 2023
Biotechnology Research🌐 imubiosciences.com
Website LinkedIn
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in IMU Biosciences?
IMU Biosciences has 1 investors on record on gritt.io, 1 mid-stage.
When did IMU Biosciences last raise funding?
The most recent investment in IMU Biosciences recorded on gritt.io was in October 2023.
When was IMU Biosciences founded?
IMU Biosciences was founded in 2019.
What industry is IMU Biosciences in?
IMU Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IMU Biosciences based?
IMU Biosciences is headquartered in London, United Kingdom.